Drugs News and Research

RSS

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.

25 Feb 2011

Researchers to share information on delirium at ADS conference

At least seven million hospitalized Americans suffer from delirium each year, however the condition goes unrecognized in more than 60 percent of patients. Even if diagnosed, there is no effective way to treat the condition, which is a growing concern to medical professionals.

25 Feb 2011

New 'closed-loop' system can provide tightly controlled anesthesia in patients undergoing surgery

A new 'closed-loop' system can precisely adjust levels of anesthetics and analgesic drugs in patients undergoing surgery, reports a study in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

25 Feb 2011

New study: Multiple full-term pregnancies may have higher risk of 'triple-negative' breast cancer

Full-term pregnancy has long been associated with a reduced risk of breast cancer, but a new study finds that the more times a woman gives birth, the higher her risk of "triple-negative" breast cancer, a relatively uncommon but particularly aggressive subtype of the disease.

24 Feb 2011

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, today announced the successful completion of a Phase 1 exposure-escalation clinical study with its synthetic defensin-mimetic antibiotic, PMX-30063.

24 Feb 2011

Steroid administration may impact immune system in children with asthma

Children experiencing an asthma attack who are treated with a short burst of oral steroids may have a transient depression of immune response according to a new study led by Universit- de Montr-al.

24 Feb 2011

Study examines several homicides involving anesthetic drugs, outlines anesthesiologists' experiences

A study published in March's issue of Anesthesiology examines several homicides involving anesthetic drugs and calls on anesthesiologists to assist in the investigation and prosecution of criminals who divert and kill with these drugs.

24 Feb 2011

Special issue of Neuron journal provides new insight into recent advances in addiction research

Addiction is a brain disease that destroys lives, devastates families and tears at the very fabric of society. Effective prevention and treatment of addiction requires a clear understanding of the complex brain mechanisms that underlie addictive behaviors, and research has provided a fascinating view of how substance abuse hijacks neuronal circuits involved in reward and motivation and causes profound and persistent changes in behavior.

24 Feb 2011

New strategies to improve developing countries' access to low-cost generic drugs needed, experts say

New strategies that ensure developing countries have access to low-cost generic medicines and encourage innovation are needed, according to experts who attended a recent meeting sponsored by the WHO, World Intellectual Property Organization, and World Trade Organization (WTO) that addressed growing concern that strict intellectual property protections are limiting access to low-cost generic medicines, BMJ News reports.

24 Feb 2011

UBC study shows Canadians and Americans receive different drug information online

Americans and Canadians are getting vastly different search results when they look up prescription drug information online, says a study by researchers at the University of British Columbia.

24 Feb 2011

First patient enrolled in TXA127 Phase 2 clinical study to stimulate engraftment following transplant

Tarix Pharmaceuticals today announced enrollment of the first patient in a Phase 2 clinical study of TXA127, a pharmaceutical grade formulation of a naturally occurring peptide known to stimulate early hematopoietic precursor cells in the bone marrow.

24 Feb 2011

Senate Majority Leader will attempt to pass new one-month stopgap measure to avoid government shutdown

Senate Majority Leader Harry Reid said on Tuesday "he will attempt to pass a 'clean' one-month stopgap funding measure at current spending levels when the Senate returns next week, in a bid to avoid a government shutdown," CQ reports.

24 Feb 2011

Scientists complete protein 3D structural sequence essential for cellular function

Researchers at IRB Barcelona have completed the 3D structural sequence adopted by several essential proteins in the exchange of substances between the extra and intracellular milieu. This finding provides a global perspective of the structural changes that occur in these relevant proteins during basic cell processes, such as protein synthesis, the regulation of metabolism and cell volume, and nerve transmission.

24 Feb 2011

Accelrys releases Pipeline Pilot NGS Collection at Molecular Medicine Tri-Conference

Accelrys, Inc. (NASDAQ:ACCL), the leading scientific informatics software and services company, today announced at the Molecular Medicine Tri-Conference its entrance in the rapidly growing next generation sequencing (NGS) market with the release of the NGS Collection for Pipeline Pilot.

24 Feb 2011

Aminothiazoles as therapeutic leads for prion diseases

Scientists who examined more than 10,000 chemical compounds during the last year in search of potential new drugs for a group of untreatable brain diseases, are reporting that one substance shows unusual promise.

24 Feb 2011

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

Xenogenics Corporation, a majority owned subsidiary of MultiCell Technologies, Inc., is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation strategy to help finance expanded human clinical trials of its Ideal BioStent.

24 Feb 2011

Researchers identify low-dose, two-drug cocktail that reduces noise-induced hearing loss in mice

Whether on a battlefield, in a factory or at a rock concert, noise-induced hearing loss is one of the most common hazards people face. Researchers at Washington University School of Medicine in St. Louis have identified a low-dose, two-drug cocktail that reduces hearing loss in mice when given before they are exposed to loud noise. The drugs, already FDA-approved for other conditions, also treat hearing loss after noise exposure.

23 Feb 2011

FDA grants Fast Track designation to Sunesis' vosaroxin for treatment of AML

Sunesis Pharmaceuticals, Inc. today announced that vosaroxin, the Company's lead drug candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration for the potential treatment of relapsed or refractory acute myeloid leukemia in combination with cytarabine.

23 Feb 2011

Australia’s top scientist takes on top job

Today, the man who is known for one of Australia’s greatest medical achievements – the development of a cervical cancer vaccine – has been appointed as Chief Executive Officer of the Translational Research Institute (TRI) in Brisbane, Queensland.

23 Feb 2011

Diabetes technology granted patent in Australia

Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) a global company pioneering the development of a cell implant therapy to treat diabetes and neurodegenerative diseases, has been granted a patent by the Australian Patent Office for IMMUPEL(tm), LCT's industry-leading technology for encapsulating living cells prior to transplantation.

23 Feb 2011

Drugs News and Research

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

Researchers to share information on delirium at ADS conference

New 'closed-loop' system can provide tightly controlled anesthesia in patients undergoing surgery

New study: Multiple full-term pregnancies may have higher risk of 'triple-negative' breast cancer

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

Steroid administration may impact immune system in children with asthma

Study examines several homicides involving anesthetic drugs, outlines anesthesiologists' experiences

Special issue of Neuron journal provides new insight into recent advances in addiction research

New strategies to improve developing countries' access to low-cost generic drugs needed, experts say

UBC study shows Canadians and Americans receive different drug information online

First patient enrolled in TXA127 Phase 2 clinical study to stimulate engraftment following transplant

Senate Majority Leader will attempt to pass new one-month stopgap measure to avoid government shutdown

Scientists complete protein 3D structural sequence essential for cellular function

Accelrys releases Pipeline Pilot NGS Collection at Molecular Medicine Tri-Conference

Aminothiazoles as therapeutic leads for prion diseases

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

Researchers identify low-dose, two-drug cocktail that reduces noise-induced hearing loss in mice

FDA grants Fast Track designation to Sunesis' vosaroxin for treatment of AML

Australia’s top scientist takes on top job

Diabetes technology granted patent in Australia

Drug Discovery - Second Edition eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News